Ho Wah Genting Berhad Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	11.6yrs
Board average tenure	5.9yrs

Recent management updates

Recent updates

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

Oct 26

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

Jul 17

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

CEO

Ho Wah Genting Berhad has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Ooi Lim	Executive Chairman	2.8yrs	no data	0.17% MYR 79.1k
Wee Lim	Executive Director	13.9yrs	no data	0.12% MYR 57.5k
Hui Lim	Founder	12.9yrs	no data	no data
Yew Lam	Chief Financial Officer	3.1yrs	no data	no data
Doh Ling	Head of Executive Chairman Department	2.8yrs	no data	no data
Tiew Teo	President Director of PT. Ho Wah Genting Indonesia	22.8yrs	no data	0.19% MYR 90.9k
Kim Hong	Company Secretary	11.6yrs	no data	no data

11.6yrs

Average Tenure

51yo

Average Age

Experienced Management: HWGB's management team is seasoned and experienced (11.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Ooi Lim	Executive Chairman	2.8yrs	no data	0.17% MYR 79.1k
Wee Lim	Executive Director	13.9yrs	no data	0.12% MYR 57.5k
Ai Tan	Senior Independent Non-Executive Director	11.3yrs	RM43.00k	no data
Khi Yeoh	Independent Non-Executive Director	5.9yrs	RM43.00k	no data
Khalid Bin Ahmad Husni	Independent & Non Executive Director	1.9yrs	RM31.50k	no data

5.9yrs

Average Tenure

43yo

Average Age

Experienced Board: HWGB's board of directors are considered experienced (5.9 years average tenure).

Ho Wah Genting Berhad Management

Management criteria checks 2/4

Key information

Recent management updates

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Recent updates

Full year 2023 earnings released: EPS: RM0.007 (vs RM0.01 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

New major risk - Market cap size

New minor risk - Shareholder dilution

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Full year 2022 earnings released: RM0.003 loss per share (vs RM0.009 loss in FY 2021)

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.007 loss in 2Q 2022)

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad has completed a Follow-on Equity Offering in the amount of MYR 2.939792 million.

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad Update on Phase 4 United States Food and Drug Administration Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

New 90-day low: RM0.55

Full year 2020 earnings released: RM0.044 loss per share (vs RM0.019 loss in FY 2019)

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Receives Product Registration Approval for Astramern Astra H Capsule from NPRA for A Period Commencing 14 January 2021 to 14 January 2026

Ho Wah Genting Berhad Enters into Memorandum of Understanding with Chongqing ISIA Bio-Technology Co., Ltd (ISIA) to Manufacture and Produce in Vitro Diagnostic Products

New 90-day low: RM0.59

Ho Wah Genting Berhad Provides Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

New 90-day high: RM0.89

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Third quarter 2020 earnings released: RM0.002 loss per share

Ho Wah Genting Berhad Enters into Memorandum of Understanding with GNOSIS LABORATORIES (M) SDN BHD

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Ho Wah Genting Berhad Announces Appointment as the Authorized Sale Agent/ Distributor for the Covid-19 related products from Wuhan Easy Diagnosis Biomedicine Co.,Ltd

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Ho Wah Genting Berhad Announces Redesignation of Mr. Kenny Yeoh Khi Khen from Independent and Non Executive Member of Risk Committee to Chairman of Risk Committee

First half earnings released

Dato Lim Ooi Hong, Lim Wee Kiat and Datuk Teo Tiew, Executive Directors of Ho Wah Genting Berhad completed the acquisition of remaining 70.24% stake in Ho Wah Genting Berhad (KLSE:HWGB).

New 90-day high - RM0.60

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age